Elevance Health (ELV) vs Illumina (ILMN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Illumina (ILMN) has outperformed Elevance Health (ELV) over the past year, gaining 177.0% versus a gain of 13.1%. Over five years, ELV leads with a +2.9% price change compared with -32.9% for ILMN. Elevance Health is the larger company by market cap ($87.68 billion vs $40.43 billion), about 2.2 times the size.
On valuation, Elevance Health trades at a lower forward P/E (13.7x vs 43.8x for Illumina). Elevance Health pays a dividend yielding 1.70%, while Illumina does not currently pay one. Illumina converts more of its revenue into profit, with a net margin of 19.6% versus 2.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELV | ILMN |
|---|---|---|
| Share price | $404.31 | $267.76 |
| Market cap | $87.68B | $40.43B |
| 1-day change | +1.05% | -2.11% |
| YTD return | +15.34% | +104.15% |
| 1-year return | +13.10% | +176.95% |
| 5-year return | +2.86% | -32.85% |
| P/E ratio (TTM) | 17.90 | 49.96 |
| Forward P/E | 13.69 | 43.83 |
| EPS (TTM) | $22.59 | $5.36 |
| Dividend yield | 1.70% | 0.00% |
| Annual dividend | $6.86 | $0.00 |
| Revenue (latest FY) | $199.13B | $4.34B |
| Revenue growth (YoY) | +12.49% | -0.66% |
| Net income (latest FY) | $5.66B | $850.00M |
| Gross margin | 89.36% | 66.08% |
| Operating margin | 3.62% | 18.58% |
| Net margin | 2.84% | 19.57% |
| 52-week high | $436.24 | $309.35 |
| 52-week low | $274.84 | $88.00 |
| Distance from 52-week high | -7.32% | -13.44% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +11.67% | -16.40% |
| Average volume | 1.20M | 2.66M |
| Shares outstanding | 216.87M | 151.00M |
| Employees | 96,129 | 8,600 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Elevance Health is about 2.2 times larger than Illumina by market value ($87.68B vs $40.43B).
- ILMN has outperformed ELV by 163.9 percentage points over the past year.
- Illumina trades at a higher earnings multiple (50.0x vs 17.9x trailing P/E).
- Elevance Health offers a meaningfully higher dividend yield (1.70% vs 0.00%).
- Illumina is more profitable, keeping 19.6 cents of every revenue dollar as net income versus 2.8 cents for Elevance Health.
- Elevance Health grew revenue faster in its latest fiscal year (+12.49% vs -0.66%).
About Elevance Health
ELV stock →Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Health Care · Medical Specialities · 96,129 employees
About Illumina
ILMN stock →Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
Health Care · Medical Specialities · 8,600 employees
ELV vs ILMN FAQ
Which is bigger, Elevance Health or Illumina?
Elevance Health (ELV) is larger, with a market capitalization of $87.68B compared with $40.43B for Illumina (ILMN).
Which stock has performed better over the past year, ELV or ILMN?
ILMN returned +176.95% over the past 12 months, compared with +13.10% for ELV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ELV or ILMN?
ELV has the lower trailing P/E at 17.9, versus 50.0 for ILMN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Elevance Health or Illumina?
Elevance Health pays a dividend yielding 1.70%, while Illumina does not currently pay a regular dividend.
Are Elevance Health and Illumina in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.